A Single-center, Open-label, Multiple-dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Levetiracetam Administered as Intravenous Infusion in Japanese and Caucasian Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2014
At a glance
- Drugs Levetiracetam (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors UCB Japan
- 28 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Dec 2012 New trial record